BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND RBM10, GPATC9, 8241, ENSG00000182872, CTD-2522E6_5, GPATCH9, KIAA0122, P98175, MGC1132, DXS8237E, ZRANB5, MGC997 AND Prognosis
3993 results:

  • 1. Integrated analysis identified the role of three family members of ARHGAP in pancreatic adenocarcinoma.
    Fei H; Shi X; Sun D; Yang H; Wang D; Li K; Si X; Hu W
    Sci Rep; 2024 May; 14(1):11790. PubMed ID: 38783033
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The footprint of gut microbiota in gallbladder cancer: a mechanistic review.
    Liu S; Li W; Chen J; Li M; Geng Y; Liu Y; Wu W
    Front Cell Infect Microbiol; 2024; 14():1374238. PubMed ID: 38774627
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Ciprofol suppresses proliferation, invasion and migration of human pancreatic cancer cells.
    Han F; Dong S; Chen Z; Dong C; Shi H; Du Y; Zhou W
    Pak J Pharm Sci; 2024 Mar; 37(2):327-336. PubMed ID: 38767100
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. E3 ubiquitin ligase UBR5 promotes gemcitabine resistance in pancreatic cancer by inducing O-GlcNAcylation-mediated EMT via destabilization of OGA.
    Du Y; Yang Z; Shi H; Chen Z; Chen R; Zhou F; Peng X; Hong T; Jiang L
    Cell Death Dis; 2024 May; 15(5):340. PubMed ID: 38755129
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Differentially expressed genes associated with high metabolic tumor volume served as diagnostic markers and potential therapeutic targets for pancreatic cancer.
    Kim BG; Lee SH; Jang Y; Kang S; Kang CM; Cho NH
    J Transl Med; 2024 May; 22(1):453. PubMed ID: 38741142
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Analysis of factors affecting the prognosis of patients with pancreatic cancer patients with obstructive jaundice].
    Zhang L; Li M; Sun QF; Yu HP
    Zhonghua Nei Ke Za Zhi; 2024 May; 63(5):474-479. PubMed ID: 38715484
    [No Abstract]    [Full Text] [Related]  

  • 7. Correlation of gasdermin B staining patterns with prognosis, progression, and immune response in colorectal cancer.
    Sun L; Wang J; Li Y; Kang Y; Jiang Y; Zhang J; Qian S; Xu F
    BMC Cancer; 2024 May; 24(1):567. PubMed ID: 38711020
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Bilateral efforts to improve SERS detection efficiency of exosomes by Au/Na
    Zhao Q; Cheng X; Hu S; Zhao M; Chen J; Mu M; Yang Y; Liu H; Hu L; Zhao B; Song W
    Biosens Bioelectron; 2024 Aug; 258():116349. PubMed ID: 38705072
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical impact of high-quality testing for peritoneal lavage cytology in pancreatic cancer.
    Tanemura M; Furukawa K; Mikamori M; Asaoka T; Yasuoka H; Marukawa D; Urata Y; Yamada D; Kobayashi S; Eguchi H
    Sci Rep; 2024 May; 14(1):10199. PubMed ID: 38702437
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study.
    Kastellan S; Kalb R; Sajjad B; McReynolds LJ; Giri N; Samuel D; Milde T; Elbracht M; Holzhauer S; Niewisch MR; Kratz CP
    J Hematol Oncol; 2024 Apr; 17(1):26. PubMed ID: 38685107
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Surgical treatment improves overall survival of hepatocellular carcinoma with extrahepatic metastases after conversion therapy: a multicenter retrospective study.
    Zhang X; Zhu X; Zhong J; Zhao Y; Zhang X; Zhang W; Ye F; Yang C; Xue J; Xiong R; Wang J; Shen S; Pan Y; Li D; Song T; Bi X; Sun H; Xiang B; Gu S; Wen T; Lu S; Chen Y; Yin T; Liu L; Kuang M; Xu L; Li D; Cai J
    Sci Rep; 2024 Apr; 14(1):9745. PubMed ID: 38679630
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A novel multidrug-resistant cell line from a Chinese patient with pancreatic ductal adenocarcinoma.
    Tang H; Miao X; Yu C; Chai C; Su Y; Li L; Yi J; Ye Z; Miao L; Wang Z; Zhang H; Xu H; Zhou W
    Sci Rep; 2024 Apr; 14(1):9259. PubMed ID: 38649719
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prognostic value of combined psoas muscle mass and controlling nutritional status in patients with pancreatic ductal adenocarcinoma: a retrospective cohort study.
    Kuwabara S; Takeuchi Y; Sato O; Mizota T; Ichinokawa M; Murakawa K; Aoki Y; Ishido K; Ono K; Hirano S
    BMC Surg; 2024 Apr; 24(1):116. PubMed ID: 38643112
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Nuclear MAST4 Suppresses FOXO3 through Interaction with AKT3 and Induces Chemoresistance in pancreatic Ductal Carcinoma.
    Fujiwara-Tani R; Sasaki T; Bhawal UK; Mori S; Ogata R; Sasaki R; Ikemoto A; Kishi S; Fujii K; Ohmori H; Sho M; Kuniyasu H
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612866
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Calix[6]arene dismantles extracellular vesicle biogenesis and metalloproteinases that support pancreatic cancer hallmarks.
    Cordeiro HG; Azevedo-Martins JM; Faria AVS; Rocha-Brito KJP; Milani R; Peppelenbosch M; Fuhler G; de Fátima Â; Ferreira-Halder CV
    Cell Signal; 2024 Jul; 119():111174. PubMed ID: 38604340
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Prognostic value of the modified Glasgow prognostic score in biliary tract cancer patients: a systematic review and meta-analysis.
    Zhou Y; Liu Z; Cheng Y; Li J; Fu W
    J Gastrointest Surg; 2024 Apr; 28(4):559-565. PubMed ID: 38583910
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Predicting postoperative prognosis of pancreatic cancer using a computed tomography-based radio-clinical model: exploring biologic functions.
    Yu C; Ruan Y; Yu L; Wang X; Hu Z; Zhu G; Huang T
    J Gastrointest Surg; 2024 Apr; 28(4):458-466. PubMed ID: 38583896
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Upfront multi-bipolar radiofrequency ablation for HCC in transplant-eligible cirrhotic patients with salvage transplantation in case of recurrence.
    Boros C; Sutter O; Cauchy F; Ganne-Carrié N; Nahon P; N'kontchou G; Ziol M; Grando V; Demory A; Blaise L; Dondero F; Durand F; Soubrane O; Lesurtel M; Laurent A; Seror O; Nault JC
    Liver Int; 2024 Jun; 44(6):1464-1473. PubMed ID: 38581233
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. GGT5 facilitates migration and invasion through the induction of epithelial-mesenchymal transformation in gastric cancer.
    Luo Z; Chen Y; Chen B; Zhao Z; Wu R; Ren J
    BMC Med Genomics; 2024 Apr; 17(1):82. PubMed ID: 38581025
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Genome-wide CRISPR screens identify PKMYT1 as a therapeutic target in pancreatic ductal adenocarcinoma.
    Wang S; Xiong Y; Luo Y; Shen Y; Zhang F; Lan H; Pang Y; Wang X; Li X; Zheng X; Lu X; Liu X; Cheng Y; Wu T; Dong Y; Lu Y; Cui J; Jia X; Yang S; Wang L; Wang Y
    EMBO Mol Med; 2024 May; 16(5):1115-1142. PubMed ID: 38570712
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 200.